ArticleCancer discovery2016

Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.

Haikuo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.